| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 |
| filingDate |
2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b34532ef036692aa4d64de8be8add2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d82325a79cddcc45490cf73e84924c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea212bb4eaa62c01ae09bc559dcb57a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b950de9bee79efe53e7f96a9fc9e13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369fbf2e674cf48a92aaaeac2f3b43f4 |
| publicationDate |
2009-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7582651-B2 |
| titleOfInvention |
Pyrrolopyridine derivative and use thereof |
| abstract |
A novel pyrrolopyridine derivative which is a compound represented by the formula n n n n n n n n n n wherein Ring A represents an optionally substituted pyridine ring; X represents an electron-attracting group; Y represents an optionally substituted divalent C 1-6 chain hydrocarbon group; R 1 represents an optionally substituted hydrocarbon group; and R 2 and R 3 each independently represents hydrogen, an optionally substituted hydrocarbon group or an optionally-substituted heterocyclic group, or R 2 and R 3 may form an optionally substituted ring in cooperation with the adjacent nitrogen atom, or a salt of the compound. The pyrrolopyridine derivative has vanilloid receptor agonist activity and is useful as medicines such as a preventive/therapeutic agent and analgesic for overactive bladder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415048-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9532959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792326-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10278925-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105328-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105330-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012363789-B2 |
| priorityDate |
2002-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |